Clinical Trial

Relative Bioavailability of Two Orally Administered CBD Formulations in Healthy Male Adults

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 30, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
This project is aimed at understanding whether a new fast-dissolving cheek-administered cannabidiol strip will be absorbed better into the body than cannabidiol powder. The results of this study will help guide dosage formulation choices as well as dosing regimens in NFL athletes for concussion management.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-23.
Trial Details
NCT Number NCT06574100
Lead Sponsor University of Saskatchewan
Collaborators: University of Regina
Conditions Pharmacokinetics
Enrollment 20 participants
Start Date 2024-10-26
Primary Completion 2025-11 (estimated)
Study Completion 2025-11 (estimated)
Updated on ClinicalTrials.gov 2025-03-30